Dimed SA Distribuidora de Medicamentos

BOVESPA:PNVL3

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is PNVL3's stock price target?

Price Target

18.11 BRL

According to Wall Street analysts, the average 1-year price target for PNVL3 is 18.11 BRL with a low forecast of 15.15 BRL and a high forecast of 24.15 BRL.

What is Dimed SA Distribuidora de Medicamentos's Revenue forecast?

Projected CAGR

19%

For the last 8 years the compound annual growth rate for Dimed SA Distribuidora de Medicamentos's revenue is 11%. The projected CAGR for the next 2 years is 19%.

What is Dimed SA Distribuidora de Medicamentos's Operating Income forecast?

Projected CAGR

27%

For the last 8 years the compound annual growth rate for Dimed SA Distribuidora de Medicamentos's operating income is 7%. The projected CAGR for the next 2 years is 27%.

What is Dimed SA Distribuidora de Medicamentos's Net Income forecast?

Projected CAGR

49%

For the last 8 years the compound annual growth rate for Dimed SA Distribuidora de Medicamentos's net income is 9%. The projected CAGR for the next 2 years is 49%.